Healthcare | May 08, 2024
Sumitomo Corporation makes full-scale entry into private clinic business in fast-growing southeast Asia
Investing in Malaysia's largest clinic operator to expand the healthcare business
Investing in Malaysia's largest clinic operator to expand the healthcare business
The company has posted net loss of Rs. 105.07 crores for the Financial Year ended March 31, 2024
With this, for all our USFDA facilities, EIRs are in place
Travoprost Ophthalmic Solution USP, 0.004%, is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
The company has posted net profit of Rs.30.35 crores for the Financial Year ended March 31, 2024
The company has reported total income of Rs. 155.79 crores during the period ended March 31, 2024
The company has reported total income of Rs. 2,943.49 crores during the period ended March 31, 2024
The company has reported total income of Rs. 1,089.58 crores during the period ended March 31, 2024
The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Subscribe To Our Newsletter & Stay Updated
